Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Bergmann

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
The Behavioral and Brain Sciences|February 10, 2022
Improving the generalizability of infant psychological research: The ManyBabies modelIngmar Visser, Christina Bergmann, Krista Byers-Heinlein, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Journal of the American Heart Association|February 26, 2025
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research CohortAndrea-Hermina Györfi, Tim Filla, Amin Polzin, et al.
Advances in Methods and Practices in Psychological Science|July 13, 2022
A multi-lab study of bilingual infants: Exploring the preference for infant-directed speechKrista Byers-Heinlein, Angeline Sin Mei Tsui, Christina Bergmann, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
The Behavioral and Brain Sciences|February 10, 2022
Improving the generalizability of infant psychological research: The ManyBabies modelIngmar Visser, Christina Bergmann, Krista Byers-Heinlein, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Journal of the American Heart Association|February 26, 2025
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research CohortAndrea-Hermina Györfi, Tim Filla, Amin Polzin, et al.
Advances in Methods and Practices in Psychological Science|July 13, 2022
A multi-lab study of bilingual infants: Exploring the preference for infant-directed speechKrista Byers-Heinlein, Angeline Sin Mei Tsui, Christina Bergmann, et al.
Pageof 11